Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
divestment
Pharma
Boehringer Ingelheim divests biologics CDMO unit in China
Blood products developer Raas will pay up to around $3 million to secure a 100% stake in a Boehringer Ingelheim biologics CDMO unit in China.
Fraiser Kansteiner
Sep 24, 2026 11:38am
CDMO Argonaut sells of life sci and diagnostics division
Sep 11, 2026 8:33am
Bayer scores €3B capital equity infusion in deal with Apollo
Jul 10, 2026 11:31am
Stada snaps up 16 consumer health lines from Orifarm
Jun 24, 2026 11:20am
Novartis plots divestment of India business
Feb 20, 2026 9:35am
BMS sells majority stake in historic US-China pharmaceutical JV
Sep 15, 2025 10:09am